FDA Adverse Event Injury Summary report: N

INFINION CX

MDR report key: 18115756 · Received November 10, 2023

Report

Report Number
3006630150-2023-06945
Event Type
Injury
Date Received
November 10, 2023
Date of Event
October 19, 2023
Report Date
November 10, 2023
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
UDI-DI
08714729861638
PMA / PMN Number
P030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: SCS-LINEAR LEADS, UPN:M365SC2317700, MODEL: SC-2317-70, SERIAL: (B)(6), BATCH: 7083229; PRODUCT FAMILY: SCS-IPG-PC, UPN: M365SC14320, MODEL: SC-1432, SERIAL:(B)(6), BATCH: 222161.

Description of Event or Problem · 0

IT WAS REPORTED THAT FOLLOWING A SPINAL CORD STIMULATION (SCS) IMPLANT PROCEDURE, WHICH WENT WELL, WITH NO VISIBLE OR NOTICEABLE COMPLICATIONS, IT WAS NOTICED IN THE RECOVERY AREA THAT THE PATIENT WAS NOT ABLE TO MOVE HER RIGHT LEG. AN X-RAY WAS TAKEN BUT THE PHYSICIAN DID NOT SEE ANYTHING WRONG WITH THE PLACEMENT OF THE SCS DEVICE. AFTER A SHORT PERIOD OF OBSERVATION, THE PHYSICIAN MADE THE DECISION TO TRANSFER THE PATIENT TO THE HOSPITAL FOR FURTHER TESTING. THE PATIENT HAD MULTIPLE INCONCLUSIVE TESTS, INCLUDING MAGNETIC RESONANCE IMAGING (MRI). AFTER AN OVERNIGHT STAY IN THE HOSPITAL, THE PATIENTS SYMPTOMS HAD NOT IMPROVED BUT THERE WAS NOT A KNOWN CAUSE FOR HER CONDITION. THE PHYSICIAN CHOSE TO EXPLANT THE SCS SYSTEM. THE EXPLANTED DEVICES WILL NOT BE RETURNED AS THEY WERE RETAINED BY THE MEDICAL FACILITY. POST OPERATIVELY, THE PATIENT WAS IN REHAB AND HER STAPLES WERE REMOVED. THE PATIENT TOLD THE PHYSICIANS OFFICE THAT SHE'S DOING BETTER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2198564 INFINION CX STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION SC-2317-70 7083130 08714729861638

Patients

Seq Age Sex Outcome Treatment
1 77 YR Female Required Intervention